Clinical Trial Update: GDF-15 as a Biomarker for Mitochondrial Disease

View source ↗

Summary

The clinical trial evaluating GDF-15 as a biomarker for mitochondrial disease has completed. It studied mitochondrial disease, metabolic myopathy, and muscular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Myopathy
• Mitochondrial Disease
• Muscular Dystrophy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Mitochondrial Disease, Metabolic Myopathy | Status: COMPLETED